Bruker Posts 33 Percent Rise in Q2 Revenues, Notes Strong Interest in New Mass Spec Systems

While CEO Frank Laukien noted that recent mass spec releases like the maXis 4G UHR-QTOF and the maXis Impact likely hadn't contributed to the rising Q2 revenues, "order uptake is strong" for the new instruments, he said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.